Pediatric oncology survivorship: conveying risks and communicating information at the right time for the individual

Maria C McCarthy1, Monica Campo, Sarah E Drew

  • 1Children's Cancer Centre, Royal Children's Hospital, Parkville, Victoria, Australia. maria.mccarthy@rch.org.au

Insights

Childhood cancer survivors often lack awareness of long-term health risks due to insufficient communication strategies. Tailored approaches are needed to empower young individuals in their healthcare journey.

Area of Science:

  • Pediatric Oncology
  • Health Communication
  • Survivorship Care

Background:

  • Childhood cancer survivorship presents unique challenges.
  • Long-term health risks require effective communication strategies.
  • Developmental needs of pediatric populations must be considered.

Purpose of the Study:

  • To review research (2011-2013) on communication needs of childhood cancer survivors.
  • To examine risk communication in the context of developmental stages.
  • To identify gaps in understanding survivor information requirements.

Main Methods:

  • Literature review of recent research (2011-2013).
  • Analysis of studies focusing on risk communication and developmental needs.
  • Synthesis of findings related to information preferences and communication strategies.

Main Results:

  • Survivors exhibit low awareness of ongoing health risks.
  • Clinical strategies for risk communication and patient empowerment are insufficient.
  • Information needs of very young survivors are under-researched.
  • Adolescents and young adults are vulnerable due to knowledge gaps and risk-taking behaviors.
  • Internet technologies show promise for health risk communication.

Conclusions:

  • Systematic, flexible communication approaches are crucial throughout survivorship.
  • Age alone is an inadequate proxy for assessing communication capacity.
  • Addressing complex information and communication needs is essential for optimal care.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...